Clinical Trial

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to look at how safe 89Zr-DFO-SC16.56 is, and how it is processed by the body in people with small cell lung cancer.
Protocol Amendment History 3 changes
notable Enrollment increased: 53 -> 105 participants 2026-08-13
notable Primary completion pushed: 2026-06-11 -> 2027-06-11 2026-06-26
minor Completion pushed: 2026-06-11 -> 2027-06-11 2026-06-26
Trial Details
NCT Number NCT04199741
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Small Cell Lung Cancer, Small Cell Lung Carcinoma
Enrollment 105 participants
Start Date 2019-12-11
Primary Completion 2027-06-11 (estimated)
Study Completion 2027-06-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-12